Mostrar el registro sencillo del ítem

dc.contributor.author
Sookoian, Silvia Cristina  
dc.contributor.author
Pirola, Carlos José  
dc.date.available
2018-03-23T19:59:02Z  
dc.date.issued
2016-05  
dc.identifier.citation
Sookoian, Silvia Cristina; Pirola, Carlos José; Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype; Mexican Association of Hepatology; Annals of Hepatology; 15; 4; 5-2016; 604-609  
dc.identifier.issn
1665-2681  
dc.identifier.uri
http://hdl.handle.net/11336/39854  
dc.description.abstract
Article commented: Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Mexican Association of Hepatology  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
Nafld  
dc.subject
Nash  
dc.subject
Treatment  
dc.subject
Elafibranor  
dc.subject.classification
Medicina Critica y de Emergencia  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-03-15T14:09:43Z  
dc.journal.volume
15  
dc.journal.number
4  
dc.journal.pagination
604-609  
dc.journal.pais
México  
dc.description.fil
Fil: Sookoian, Silvia Cristina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Pirola, Carlos José. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.journal.title
Annals of Hepatology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-elafibranor-for-treatment-nafld-one-S1665268119311524  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.5604/16652681.1203165